Ask your AI about this

Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:

Connect your AI · Plans and the 7-day free trial (card required)

Buying and selling by quarter

Dollars bought and sold on the open market over the last two years.

$0$5.0M$10.0M$15.0MQ4 2024 · Bought: $0Q4 2024 · Sold: $498,716Q4 2024Q4 2025 · Bought: $0Q4 2025 · Sold: $1,740,600Q4 2025Q1 2026 · Bought: $0Q1 2026 · Sold: $1,901,554Q1 2026Q2 2026 · Bought: $0Q2 2026 · Sold: $2,809,508Q2 2026Q3 2026 · Bought: $0Q3 2026 · Sold: $10,784,659Q3 2026

Bought Sold

By trade date, using the shares and price reported for each trade. Stock grants, option exercises and shares withheld for tax are left out.

Roles

The companies where this person reports as an insider, and their position at each, most recent first.

Roles by company
TXG
10x Genomics, Inc.
DirectorNov 6, 2026
CAI
Caris Life Sciences, Inc.
DirectorAug 14, 2026
GKOS
Glaukos Corporation
PRESIDENT & COOAug 13, 2026

Roles come from the filings themselves and can change over time.

Latest open-market trades

Purchases and sales at every company, most recent filing first.

Latest insider trades
How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss.Filing
Aug 11, 2026GKOS
Glaukos Corporation
Sale27,963$178.89$5.0M+37.1%Form 4 ↗
Aug 11, 2026GKOS
Glaukos Corporation
Sale32,037$180.49$5.8M+37.1%Form 4 ↗
May 1, 2026GKOS
Glaukos Corporation
Sale19,573$143.54$2.8M+70.6%Form 4 ↗
Jan 22, 2026GKOS
Glaukos Corporation
Sale2,406$126.10$303.4K+85.7%Form 4 ↗
Jan 22, 2026GKOS
Glaukos Corporation
Sale3,100$127.03$393.8K+85.7%Form 4 ↗
Jan 22, 2026GKOS
Glaukos Corporation
Sale1,798$128.07$230.3K+85.7%Form 4 ↗
Jan 22, 2026GKOS
Glaukos Corporation
Sale3,194$129.28$412.9K+85.7%Form 4 ↗
Jan 21, 2026GKOS
Glaukos Corporation
Sale4,502$124.65$561.2K+87.8%Form 4 ↗
Nov 18, 2025GKOS
Glaukos Corporation
Sale19,340$90.00$1.7M+153.9%Form 4 ↗
Dec 20, 2024GKOS
Glaukos Corporation
Sale2,036$149.54$304.5K+35.2%Form 4 ↗
Dec 20, 2024GKOS
Glaukos Corporation
Sale1,292$150.35$194.3K+35.2%Form 4 ↗
Oct 30, 2024GKOS
Glaukos Corporation
Sale2,275$138.97$316.2K+47.1%Form 4 ↗

Each row links to its Form 4. Since trade compares the stock’s move from the close on the trade date (or the next trading day) to its latest close with the S&P 500 over the same days, adjusted for splits and excluding dividends. It describes the stock, not what the trader made: we don’t know their purchase price, position size or later sales. A dash means the trade isn’t matched to a listed stock, or there is no closing price after it yet.

When several people report on the same filing, we list it under the first one named, so trades by someone usually listed second may be missing here. Information, not investment advice: see the disclaimer.